Developer docs
API playgroundTry for free, no card

Search company profiles

Phar

Full company profile

uuid000nw8r

Namestring
Phar
Websiteurl
pharllc.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Phar is an entity operating under the domain pharllc.com. The provided source material contains no substantive information about the company's products, services, technology, customers, or business model. The company's own website displays only a CAPTCHA/verification placeholder ("One moment, please... Please wait while your request is being verified...") with no operational content.

No headcount, office locations, management team, ownership structure, parent company, funding history, partnerships, patents, certifications, regulatory actions, or operating geographies are disclosed in any of the aggregated source blocks. Company type is tentatively inferred to be private based on the LLC-style domain, but this cannot be definitively confirmed from the data. No app, API, SDK, or third-party integrations are documented.

Given the complete absence of substantive source material, this description reflects the data gap itself rather than identifiable company operations. Any further characterization of Phar's business model, technology stack, go-to-market motion, customer base, or competitive positioning would be unsupported speculation.

Short descriptiontext

Phar operates as an entity registered at the domain pharllc.com. No products, services, technology, customer segments, or business model information is available from the company website or any provided source material.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBeverly Hills, United States
HQ citystring
Beverly Hills
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Product category
Unknown
No data
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

No substantive information about the company's offerings is available in the source data; the website (pharllc.com) displayed only a CAPTCHA/verification placeholder page.

Differentiator
Functional benefit
Problem solved
No data
Market position
Customer concentration

Classification, Details

No data
Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Phar

Phar operates as an entity registered at the domain pharllc.com. No products, services, technology, customer segments, or business model information is available from the company website or any provided source material.

What Phar does

Phar is an entity operating under the domain pharllc.com. The provided source material contains no substantive information about the company's products, services, technology, customers, or business model. The company's own website displays only a CAPTCHA/verification placeholder ("One moment, please... Please wait while your request is being verified...") with no operational content.

No headcount, office locations, management team, ownership structure, parent company, funding history, partnerships, patents, certifications, regulatory actions, or operating geographies are disclosed in any of the aggregated source blocks. Company type is tentatively inferred to be private based on the LLC-style domain, but this cannot be definitively confirmed from the data. No app, API, SDK, or third-party integrations are documented.

Given the complete absence of substantive source material, this description reflects the data gap itself rather than identifiable company operations. Any further characterization of Phar's business model, technology stack, go-to-market motion, customer base, or competitive positioning would be unsupported speculation.

Phar firmographics

Firmographics
Name
Phar
Website
https://pharllc.com
Company type
Private
Founded year
2004
Headcount range
11–50 employees
Short description
Phar operates as an entity registered at the domain pharllc.com. No products, services, technology, customer segments, or business model information is available from the company website or any provided source material.
Ownership category
akta.pro rank

Where Phar is headquartered

Location

Headquarters

HQ city
Beverly Hills
HQ country
United States
HQ region
North America

Markets served

Phar business model

Business model
GTM type
B2B
Offering type
Services

Phar product offering

Product offering

Core offering

No substantive information about the company's offerings is available in the source data; the website (pharllc.com) displayed only a CAPTCHA/verification placeholder page.

Differentiator

Problem solved

Functional benefit

Phar technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Phar competitors and assessment

Company assessment

Market position

Customer concentration

Phar financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Phar leadership team

Management profile

Number of profiles

Phar funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Phar M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phar

What does Phar do?

No substantive information about the company's offerings is available in the source data; the website (pharllc.com) displayed only a CAPTCHA/verification placeholder page.

Is Phar a public or private company?

Phar is a private company. It is classified as unknown.

When was Phar founded?

Phar was founded in 2004. It employs 11 to 50 people.

Where is Phar based?

Phar is headquartered in Beverly Hills, United States, in the North America region.

Does Phar have an API?

No public API is recorded for Phar.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePHAR LLC announces the appointment of Mallik Greene, BPharm, PhD, DBA to the position of Vice President, Health Economics and Outcomes ResearchPHAR LLC announced the appointment of Mallik Greene, BPharm, PhD, DBA as Vice President for Health Economics and Outcomes Research. Dr. Greene brings nearly two decades of pharmaceutical industry experience from companies including Eli Lilly, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Otsuka, and Vertex Pharmaceuticals, with over 200 peer-reviewed publications across multiple therapeutic areas. The company states the hire is timely given rising costs, expensive new products, and heightened scrutiny facing the pharmaceutical industry, which increase the challenge HEOR professionals face in developing clear value propositions.PR NewswireBiased Estimates Miss by Billions: Extensive Analysis Finds Actual Cost of New Drugs Is Far Less than PredictedPartnership for Health Analytic Research (PHAR, LLC) published a peer-reviewed study in Current Medical Research and Opinion finding that pre-launch predictions of pharmaceutical costs are frequently and dramatically overestimated. The study examined 25 drug launch predictions since 2012, finding that 10 were off by more than $1 billion, including ICER's $7.2 billion estimate for PCSK9 inhibitors versus actual 2016 sales of just $192 million. Researchers warn that such overestimates may lead health insurers to unnecessarily restrict patient access to treatments that are more cost-effective than predicted.